Next Article in Journal
Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical Models
Previous Article in Journal
Local Disease-Free Survival Rate (LSR) Application to Personalize Radiation Therapy Treatments in Breast Cancer Models
Previous Article in Special Issue
Comparison of Serum Pharmacodynamic Biomarkers in Prednisone-Versus Deflazacort-Treated Duchenne Muscular Dystrophy Boys
Open AccessReview

Modelling Neuromuscular Diseases in the Age of Precision Medicine

Department of Paediatrics, University of Oxford, Oxford OX1 3QX, UK
*
Author to whom correspondence should be addressed.
J. Pers. Med. 2020, 10(4), 178; https://doi.org/10.3390/jpm10040178
Received: 23 September 2020 / Revised: 14 October 2020 / Accepted: 15 October 2020 / Published: 17 October 2020
Advances in knowledge resulting from the sequencing of the human genome, coupled with technological developments and a deeper understanding of disease mechanisms of pathogenesis are paving the way for a growing role of precision medicine in the treatment of a number of human conditions. The goal of precision medicine is to identify and deliver effective therapeutic approaches based on patients’ genetic, environmental, and lifestyle factors. With the exception of cancer, neurological diseases provide the most promising opportunity to achieve treatment personalisation, mainly because of accelerated progress in gene discovery, deep clinical phenotyping, and biomarker availability. Developing reproducible, predictable and reliable disease models will be key to the rapid delivery of the anticipated benefits of precision medicine. Here we summarize the current state of the art of preclinical models for neuromuscular diseases, with particular focus on their use and limitations to predict safety and efficacy treatment outcomes in clinical trials. View Full-Text
Keywords: neuromuscular diseases; translational research; disease models; precision medicine neuromuscular diseases; translational research; disease models; precision medicine
MDPI and ACS Style

Speciale, A.A.; Ellerington, R.; Goedert, T.; Rinaldi, C. Modelling Neuromuscular Diseases in the Age of Precision Medicine. J. Pers. Med. 2020, 10, 178.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop